Top Markets
#1 Black Phoenix Black Phoenix +355.20%
#2 Glidr Glidr +84.34%
#3 Gold Park Gold Park +62.60%
#4 Akedo Akedo +60.88%
#5 OpenEden OpenEden +54.74%
#6 Acurast Acurast +29.22%
#7 BasedHype BasedHype +27.20%
#8 Cryptopia Cryptopia +21.54%
#9 Avantis Avantis +18.96%
#10 Ether.fi Ether.fi +17.29%
Coin of the day
Black Phoenix Black Phoenix
Beállítások
Nyelv
MAGYAR
Pénznem
USD
Téma
China Jo-Jo Drugstores, Inc. China Jo-Jo Drugstores, Inc.

China Jo-Jo Drugstores, Inc.

CJJD
Helyezés a részvények között #40595
China Jo-Jo Drugstores, Inc., along with its subsidiary entities, functions as... China Jo-Jo Drugstores, Inc., along with its subsidiary entities, functions as a prominent retailer and distributor of a wide array of pharmaceutical and healthcare products across the People's Republic of China. Its operations are structured into four distinct segments: retail pharmacies, an online drugstore, wholesale drug distribution, and the cultivation of medicinal herbs. The company's brick-and-mortar stores supply customers with diverse pharmaceutical items, including both prescription and over-the-counter medications, nutritional supplements, traditional Chinese remedies, personal and family care products, and medical devices. Beyond these, they also stock everyday convenience goods such as consumables, seasonal items, and promotional merchandise. To further enhance customer service, these locations feature licensed practitioners of both Western and Traditional Chinese Medicine, available at scheduled times for consultations, examinations, and the treatment of common ailments. Additionally, China Jo-Jo Drugstores operates an internet-based pharmacy, marketing over-the-counter medications and health supplements directly to consumers, as well as leveraging third-party e-commerce platforms for sales. The enterprise also engages in the wholesale supply of third-party pharmaceutical goods, primarily to trading companies, and manages the cultivation and distribution of herbs utilized in Traditional Chinese Medicine. As of March 31, 2021, the company maintained a network of 109 retail pharmacies operating under the 'Jiuzhou Grand Pharmacy' brand, supplemented by four other drugstores. Founded in 2003, the firm's corporate headquarters are situated in Hangzhou, People's Republic of China.
Részvényárfolyam
$1.05
Utolsó szinkronizálás: 2025-03-31
Piaci kapitalizáció
$114.95K
Változás (1 nap)
0.00%
Változás (1 év)
0.00%
Ország
CN
Kereskedés China Jo-Jo Drugstores, Inc. (CJJD)

Kategória

Healthcare
Bevétel a(z) China Jo-Jo Drugstores, Inc. (CJJD) részvényhez
Bevétel ekkor: Mar 2024 TTM: $154.54M
China Jo-Jo Drugstores, Inc. legfrissebb pénzügyi jelentései szerint a vállalat jelenlegi árbevétele (TTM) $154.54M. 2023 évben a vállalat $148.81M árbevételt ért el, amely csökkenés a 2022 évben elért $164.39M árbevételhez képest. Az árbevétel az a teljes összeg, amit a vállalat termékek vagy szolgáltatások eladásából generál. A nyereséggel ellentétben ebből nem vonódnak le költségek.
China Jo-Jo Drugstores, Inc. bevételtörténete 2007 és 2026 között
Bevétel az év végén
Év Bevétel Változtassa meg
2026 (TTM) $154.54M 0.00%
2024 $154.54M 3.85%
2023 $148.81M -9.48%
2022 $164.39M 23.48%
2021 $133.13M 13.47%
2020 $117.33M 9.09%
2019 $107.55M 11.90%
2018 $96.11M 17.93%
2017 $81.50M -8.50%
2016 $89.07M 15.83%
2015 $76.90M 16.24%
2014 $66.15M -26.08%
2013 $89.50M -5.15%
2012 $94.35M 34.85%
2011 $69.97M 26.81%
2010 $55.17M 0.00%
2008 0.00 0.00%
2007 0.00 0.00%
Hasonló cégek vagy versenytársak bevétele
Vállalat Bevétel Bevételkülönbség Ország
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
 $2.54B 1,540.99%
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
 - -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
 - -
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
 - -
IT
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
 $830.81M 437.60%
US